InvestorsHub Logo

Gramps

01/05/18 9:30 AM

#119131 RE: cashpot #119119

Good stuff cashpot. To the moon.

I believe NHS news is bigger then FDA approval. Because it is very difficult to get space in a box store. But getting a device paid for is a giant leap. Everyone wants something for free and one commercial in the UK about the benefits of the actipatch, will send sales to the moon.

Simpsonly

01/05/18 11:19 AM

#119177 RE: cashpot #119119

Close cashpot, but not quite.....
Yes, most of the world expects something free for no effort, not true, rather, not quite applicable, in the case of UK NHS and the thought culture of its universal healthcare.

NHS is funded by public coffers, taxes, so Brits legitimately ‘expect’ drugs and devices to be part of ‘their’ Tariff coverage if it is good for ‘them’. NHS has stated, if your Doc writes a prescription for BIEL, you trot along to your Boots pharmacy, get it filled and NHS will pick up the tab. Now, and only now, do you think that with the efficacy, safety, costs and savings numbers of BIEL and NHS, that Big Pharmacos are gasping for oxygen????

The smart ones are scrambling on intel because pain drugs just got kicked in the berries. The smartest are already consulting with their M&A people because drug analgesics are going south in the UK and BIEL should go north passing somewhere on the M1......

Think of it in light of everything.....hundreds of millions in acute and chronic pain, unbelievable effect numbers on pain management numbers, reduces edema, stimulates healing at the cellular level, extraordinary economics of usage, not one negative side-effect, ever, and it’s patented by our USPTO.....and just legitimized for reimbursement by the largest universal healthcare system on earth. Only 2 words come to mind, if I am CEO of a Big Pharmaco, “how much?” Because my pain drug division just took one in the berries.....

When? You know when......yesterday

srinsocal

01/06/18 1:24 AM

#119257 RE: cashpot #119119

Great point cashpot, IMO NHS Coverage is very close in importance to our FDA Clearance. FDA was critical and undoubtedly helped with the NHS Approval but does not, by its self, generate revenue.

Having the most well known government funded healthcare system in the world supply ActiPatch to its members is not only a PR Bonanza but also a steady stream of revenue.